prev
next
http://Woman%20smiling%20in%20a%20head%20scarf

TARGETED THERAPIES
FOR BRAIN TUMORS

LEARN ABOUT CLINICAL TRIAL OPPORTUNITIES FOR YOUR PATIENTS
When faced with delivering a brain tumor diagnosis, you are working against the clock to present your patient with a promising treatment plan. Exploring treatment options can be an overwhelming and discouraging process. The Ivy Brain Tumor Center is here to serve as a resource to the world’s brain tumor community.

Stay Informed on New Clinical Trials

Promising Results
Announced at AACR

The Ivy Brain Tumor Center at Barrow Neurological Institute announced initial results from a Phase 0/1b clinical trial of AZD1390, in combination with radiation therapy, in newly diagnosed, MGMT-unmethylated glioblastoma. Results from this study will be presented by Dr. Nader Sanai at the American Association for Cancer Research Annual Meeting and demonstrate that AZD1390 may be a potent radiosensitizer in both newly diagnosed and recurrent glioblastoma patients.

Clinical Trials at the Ivy Center

When a patient is referred to a clinical trial at the Ivy Brain Tumor Center, we partner with their physicians and treatment team on a path forward. While assessing a patient’s suitability for our clinical trials program, our dedicated team supports the physicians managing these cases. We work in partnership to create a patient-centered path forward.

Novel study designs aimed at assessing blood-brain barrier (BBB) penetration

Large portfolio of clinical trials investigating targeted therapies

Complimentary clinical trial screening for your patients

Collaborative partnerships with referring physicians

woman wearing a bandana and holding a mug

Is Your Patient Eligible?

Download our clinical trial overview sheet to discover if our trials offer a potential treatment option for your patients.

Download Now